The slip
PARKINSON RECEIPTno. 6013
22 Oct 2026, 03:15 UTCmicroglia, braak
predictionITGAX in microglia tracks Braak Lewy-body stage
registeredf521b0abcea84fb6
discovery+0.41 p=0.273 n=9
replication+0.03 p=0.946 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.41, p 0.273)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT35a0b4214ab4c219e9ea7ca2…
follows f6da5fc1cdd6…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 6013: ITGAX in microglia, braak
- power
- full sample +0.26 (p 0.306, n 18), 95% CI -0.24 to +0.65. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.20 (p 0.418, n 18). does not hold up.
- composition
- microglia share of nuclei vs axis -0.11 (p 0.652); controlling for it: +0.27 (p 0.273, n 18). could be the mix.
- skeptic
- leave-one-out range +0.18 to +0.44, sign flips 0; without severely affected donors +0.26 (p 0.306, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ITGAX in microglia.
case closed: nothing better to follow up.